2026-2034年全球元基因组定序市场规模、份额、趋势和成长分析报告

预计元基因组定序市场将从 2025 年的 35.4 亿美元成长到 2034 年的 154.4 亿美元，2026 年至 2034 年的复合年增长率为 17.76%。

由于人们对研究微生物群落及其对健康和环境的影响日益关注，全球元基因组定序市场正经历快速成长。元基因组定序无需培养微生物即可分析环境样本中的遗传物质。这项技术广泛应用于医疗保健、农业和环境研究领域。对先进基因组分析工具日益增长的需求以及对微生物组研究的日益重视，正在推动市场扩张。

关键成长要素包括定序技术的进步和基因组分析成本的降低。总体基因体学在疾病诊断、药物研发和环境监测等领域的应用不断拓展，进一步推动了市场需求。学术机构与生技公司之间的合作正在加速创新。此外，人们对微生物在人类健康和生态系统中作用的认识不断提高，也为市场成长提供了支持。

受基因组学和生物资讯学持续进步的推动，元基因组组定序市场预计未来将显着成长。更快、更精准的定序平台的开发将提昇科研能力。新兴市场由于研发和医疗基础设施投资的增加，蕴藏着巨大的成长机会。此外，个人化医疗和环境永续性等领域的应用拓展也将进一步推动市场成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球元基因组定序市场：依产品与服务划分

• 市场分析、洞察与预测
• 试剂和耗材
• 装置
• 定序服务
• 分析和数据解释解决方案

第五章 全球元基因组定序市场：依技术划分

• 市场分析、洞察与预测
• 16S rRNA定序
• 鸟枪法元基因组组定序
• 全基因组定序与从头组装
• 宏转录组学

第六章 全球元基因组定序市场：依工作流程划分

• 市场分析、洞察与预测
• 样品处理和样品製备
• 定序
• 数据处理与分析

第七章 全球元基因组定序市场：依应用领域划分

• 市场分析、洞察与预测
• 药物发现
• 临床诊断
• 土壤微生物组的应用
• 工业应用
• 在生态与环境领域的应用
• 兽医学
• 其他用途

第八章 全球元基因组定序市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Illumina Inc
  • Thermo Fisher Scientific Inc
  • PerkinElmer Inc
  • QIAGEN NV
  • Oxford Nanopore Technologies Plc
  • Pacific Biosciences Of California Inc
  • BGI Group
  • Psomagen Inc
  • Eurofins Scientific SE
  • Azenta Inc.（formerly Part Of Brooks Automation Inc.）
  • Novogene Co. Ltd
  • Zymo Research Corporation
  • Tecan Trading AG
  • IntegraGen SA
  • Microsynth AG

The Metagenomics Sequencing Market size is expected to reach USD 15.44 Billion in 2034 from USD 3.54 Billion (2025) growing at a CAGR of 17.76% during 2026-2034.

The global metagenomics sequencing market is witnessing rapid growth due to increasing interest in studying microbial communities and their impact on health and the environment. Metagenomics sequencing enables the analysis of genetic material from environmental samples without the need for culturing organisms. This technology is widely used in healthcare, agriculture, and environmental research. The growing demand for advanced genomic tools and the rising focus on microbiome research are driving market expansion.

Key growth drivers include advancements in sequencing technologies and decreasing costs of genomic analysis. The increasing application of metagenomics in disease diagnosis, drug discovery, and environmental monitoring is further boosting demand. Collaborations between academic institutions and biotechnology companies are accelerating innovation. Additionally, the rising awareness about the role of microorganisms in human health and ecosystems is supporting market growth.

In the future, the metagenomics sequencing market is expected to grow significantly with continued advancements in genomics and bioinformatics. The development of faster and more accurate sequencing platforms will enhance research capabilities. Emerging markets are likely to offer substantial growth opportunities due to increasing investments in research and healthcare infrastructure. Furthermore, expanding applications in personalized medicine and environmental sustainability will drive market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Reagents & Consumables
• Instruments
• Sequencing Services
• Analysis & Data Interpretation Solutions

By Technology

• 16S rRNA Sequencing
• Shotgun Metagenomic Sequencing
• Whole-Genome Sequencing & De Novo Assembly
• Metatranscriptomics

By Workflow

• Sample Processing & Library Preparation
• Sequencing
• Data Processing & Analysis

By Application

• Drug Discovery
• Clinical Diagnostics
• Soil Microbiome Applications
• Industrial Applications
• Ecological & Environmental Applications
• Veterinary Applications
• Other Applications

COMPANIES PROFILED

• Illumina Inc, Thermo Fisher Scientific Inc, PerkinElmer Inc, QIAGEN NV, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, BGI Group, Psomagen Inc, Eurofins Scientific SE, Azenta Inc formerly part of Brooks Automation Inc, Novogene Co Ltd, Zymo Research Corporation, Tecan Trading AG, IntegraGen SA, Microsynth AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL METAGENOMICS SEQUENCING MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sequencing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Analysis & Data Interpretation Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL METAGENOMICS SEQUENCING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. 16S rRNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Shotgun Metagenomic Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Whole-Genome Sequencing & De Novo Assembly Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Metatranscriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL METAGENOMICS SEQUENCING MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Sample Processing & Library Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Processing & Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL METAGENOMICS SEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Soil Microbiome Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Industrial Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Ecological & Environmental Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Veterinary Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL METAGENOMICS SEQUENCING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product & Service
  • 8.2.2 By Technology
  • 8.2.3 By Workflow
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product & Service
  • 8.3.2 By Technology
  • 8.3.3 By Workflow
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product & Service
  • 8.4.2 By Technology
  • 8.4.3 By Workflow
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product & Service
  • 8.5.2 By Technology
  • 8.5.3 By Workflow
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product & Service
  • 8.6.2 By Technology
  • 8.6.3 By Workflow
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL METAGENOMICS SEQUENCING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Illumina Inc
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 PerkinElmer Inc
  • 10.2.4 QIAGEN N.V
  • 10.2.5 Oxford Nanopore Technologies Plc
  • 10.2.6 Pacific Biosciences Of California Inc
  • 10.2.7 BGI Group
  • 10.2.8 Psomagen Inc
  • 10.2.9 Eurofins Scientific SE
  • 10.2.10 Azenta Inc. (formerly Part Of Brooks Automation Inc.)
  • 10.2.11 Novogene Co. Ltd
  • 10.2.12 Zymo Research Corporation
  • 10.2.13 Tecan Trading AG
  • 10.2.14 IntegraGen SA
  • 10.2.15 Microsynth AG